China's First Ophthalmic Femtosecond-Specific Surgical Table Receives Approval
FineVision
Vision Solutions Developer
TowardPi
High-end Ophthalmic Medical Device Developer
In early July 2026, the Jiangsu Provincial Medical Products Administration approvedFeiguang Vision Technology (Nanjing) Co., Ltd.Self-developedPS-3D Electric Ophthalmic Surgical Table (Registration No.: Su Xie Zhu Zhun 20262150935)。
According to public data from the National Medical Products Administration, there are currently eight domestically produced electric surgical tables approved in China, manufactured by companies including Xinhua Medical, Weigao, Comen, Xinsheng Medical, and Meidongli. Among them,PS-3D is the first dedicated surgical table explicitly designed for ophthalmic femtosecond laser surgery scenarios., with the remaining products being mostly general-purpose electric operating tables.
Feiguang Vision is a wholly-owned subsidiary of FineVision (Nanjing) Medical Technology Co., Ltd. Established in 2022, FineVision’s core technology originates from the Wuhan National Laboratory for Optoelectronics at Huazhong University of Science and Technology, and was co-founded by Professor Zeng Shaoqun, Cao Feng, and other scholars from the center.
Professor Zeng Shaoqun is one of the scholars in China who apply femtosecond lasers to interdisciplinary biomedical research, with nearly 30 years of dedicated expertise in femtosecond laser microscopic optical imaging. In 2014, his team initiated the development of femtosecond laser corneal refractive surgery equipment, leading to the industrialization of their technological achievements and the official establishment of FineVision in 2022.
# Industry Background and Technical Features
Ophthalmic operating rooms in China have long faced two choices:
The surgical bed purchased as a complete set with the imported femtosecond laser equipment is relatively expensive;
Modified from a universal surgical table, with limitations in precision.
Prolonged use of hydraulic transmission systems carries the risk of hose aging and oil leakage, while pneumatic structures offer limited precision. Adjustment of the XYZ axes largely relies on manual operation. Although femtosecond laser technology has achieved micron-level precision, the stability of some existing surgical tables remains at the millimeter level, a discrepancy that is particularly pronounced in high-end surgical procedures.
PS-3D adopts step-and-scanServo motors paired with a fully closed-loop control system provide real-time position feedback, achieving micron-level positioning accuracy.. XYZ three-axis full-range electric adjustment allows physicians to fine-tune the alignment of the patient’s head and eyes via a handheld controller. The entire unit employs a fully electric mechanical drive system, eliminating hydraulic lines and pneumatic air reservoir structures.
# Product Portfolio
Currently, FineVision has two products approved for market launch:Disposable Negative Pressure Suction Lens (Consumable) and PS-3D Electric Ophthalmic Surgical Table. Its parent company, FineVision's core product—FineVision2000 Femtosecond Laser Corneal Refractive Surgery SystemMass production was achieved in 2024, and registration clinical trials were initiated.
# Femtosecond Laser Market Landscape
The market for femtosecond laser corneal refractive surgery equipment has long been dominated by Carl Zeiss of Germany, with its VisuMax system typically priced between RMB 8 million and RMB 12 million per unit. As of May 30, 2026, the installed base of the VisuMax 800 in China reached 143 units.No domestically produced femtosecond laser devices are currently on the market., exceptFineVisionIn addition,Wuhan Andun MedicalThe FEMTOPIA BVM1000 is also undergoing a multicenter registry clinical trial.TowardPi Medical, Xin Femto MedicalOther companies have also made relevant strategic arrangements.
In the overall high-end ophthalmic medical device market, foreign companies currently hold a significant share. While domestically produced OCT devices have captured over 50% of the market share in the ophthalmic OCT sector, niche segments such as ophthalmic surgical microscopes and femtosecond laser equipment remain dominated by imported brands.
The winning bid prices for domestically produced electric ophthalmic surgical tables mostly range from RMB 50,000 to RMB 150,000, while imported products are priced above RMB 150,000 to RMB 300,000. The market performance of the PS-3D surgical table will depend on its clinical performance, pricing strategy, and compatibility with primary equipment.
2025,The "Guidelines for Project Initiation of Ophthalmic Medical Service Price Items (Trial)" issued by the National Healthcare Security Administration establishes a separate project item for "femtosecond laser myopia correction surgery.", the project is named "Fee for Corneal Stromal Lenticule Extraction," decoupled from laser types and specific equipment, leaving room for subsequent innovative translation.
# Eye Future Insights
The approval of the PS-3D surgical table signifies progress by domestic manufacturers in the field of ancillary equipment for femtosecond laser surgery. However, market acceptance of this product will depend on its clinical performance, pricing strategy, and compatibility with primary systems. Currently, procurement of femtosecond laser surgical systems remains dominated by imported integrated solutions; whether domestically produced ancillary equipment can enter mainstream procurement lists remains to be seen.
Declaration:The information in this article is synthesized from publicly available registration data of the National Medical Products Administration, approval information from the Jiangsu Provincial Medical Products Administration, corporate public disclosures, and industry reports. It does not constitute any investment advice or product recommendation.
Ophthalmology Solution Cases
